- GlobeNewswire•21 days agoGenocea Congratulates Jessica Baker Flechtner, Ph.D. for Recognition on 2016’s 40 Women To Watch Over 40 List
CAMBRIDGE, Mass., Aug. 09, 2016-- Genocea Biosciences, Inc., a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, is delighted to congratulate Jessica Baker Flechtner, Ph.D., ...
- Associated Press•26 days ago
The Cambridge, Massachusetts-based company said it had a loss of 39 cents per share. The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
- GlobeNewswire•26 days ago
CAMBRIDGE, Mass., Aug. 04, 2016-- Genocea Biosciences, Inc., a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today reported corporate highlights and financial results ...
Genocea Biosciences, Inc. (GNCA)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Ask||5.59 x 200|
|Day's Range||4.93 - 5.20|
|52wk Range||2.56 - 11.74|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-3.50|
|Avg Vol (3m)||473,929|
|Dividend & Yield||N/A (N/A)|